Myeloma Prevention Within Reach?

Is Prevention of Myeloma Within Reach?

There is growing evidence that intervention strategies, such as dietary recommendations, lifestyle changes, and occupational precautions, might offer hope in the search for the prevention of myeloma, writes IMF Chairman Dr. Brian Durie in his blog this week. These ideas will be tested for the first time in the Black Swan Research-funded iStopMM® project in Iceland, which launched in October 2016. Read Dr. Durie’s blog.​

Register NOW for a FREE "Living Well with Myeloma" Webinar on Nutrition

Register for this FREE 45-minute “Living Well with Myeloma” webinar on Nutrition on Thursday, June 1st at 7 PM ET / 4 PM PT. Hosted by Kylie Buchan of Savor Health, the talk will be followed by a 15-minute Q&A from callers.

 

The BOSTON Clinical Trial Is Accruing Myeloma Patients

The BOSTON trial compares selinexor + Velcade + low-dose dexamethasone (SVd) to Velcade + low-dose dexamethasone (Vd). Selinexor is a novel, first-in-class, orally administered “Selective Inhibitor of Nucelar Export” (SINE™) compound. The BOSTON trial is enrolling myeloma patients who have been treated with 1 to 3 prior regimens and have disease that has progressed during or within 60 days after prior treatment. Trial participants will be randomly assigned but will know whether they are receiving SVd or Vd.

 

Calling All Researchers: Submit Your Grant Applications!

The Brian D. Novis Research Grants honor the IMF’s founder Brian Novis, who died of multiple myeloma in July of 1992. The grants are awarded to researchers in the field of multiple myeloma and related disorders including SMM (smoldering multiple myeloma), MGUS (monoclonal gammopathy of undetermined significance), and immunoglobulin-derived amyloidosis. The 2018 grants will fund senior research projects with $80,000 and junior research projects with $50,000. Tuesday, August 1st, 2017, is the deadline for applications.

 

Updated 2017 IMF Educational Publications Available to Order or to Download

IMF’s educational publications Understanding Kyprolis® (carfilzomib) for InjectionUnderstanding Revlimid® (lenalidomide), and Understanding Your Test Results have been updated for 2017. All are available as FREE PDF downloads or to order at https://www.myeloma.org/publications.

 

 

IMF to Host Regional Community Workshop in Buffalo, New York - June 17 th, 2017

The IMF-sponsored Regional Community Workshop in Buffalo, NY, on June 17th is open for FREE registration. The event will feature myeloma experts Dr. Philip McCarthy (Roswell Park Cancer Institute), Dr. Pallawi Torka (Roswell Park Cancer Institute), and Deborah Doss, RN, OCN (Dana Farber Cancer Institute).

 


We Would Like to Thank Our Sponsors: Takeda, Celgene, Amgen, and Bristol-Myers Squibb